Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multi-center, Randomized, Double-Masked and Vehicle-Controlled Study Evaluating the Efficacy and Safety of the Melanocortin, PL9643 Ophthalmic Solution, Compared to Vehicle in Subjects with Dry Eye

NCT05201170 is registered in ClinicalTrials.gov with Palatin Technologies, Inc as lead sponsor.

NCT NCT05201170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05201170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multi-center, Randomized, Double-Masked and Vehicle-Controlled Study Evaluating the Efficacy and Safety of the Melanocortin, PL9643 Ophthalmic Solution, Compared to Vehicle in Subjects with Dry Eye
Lead sponsor
Palatin Technologies, Inc
Phase
Phase 3
Overall status
Completed
Start date
December 30, 2021
Completion date
November 21, 2023
Enrollment
575 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, dry eye syndromes